Skip to main navigation
Skip to main content

Main Utility

  • Patients & Caregivers
  • Healthcare Professionals
  • Clinical Trials
  • Presentation & Publications
  • Investors & News
twitter linkedin

Main navigation

  • Discovery Platform
  • Pipeline
    • Ripretinib
    • Vimseltinib
    • DCC-3116
    • Preclinical Pipeline
    • Expanded Access
  • Our Medicine
    • QINLOCK® (ripretinib)
  • Who We Are
    • Management
  • Join Us
    • Open Positions

Main navigation

  • Discovery Platform
  • Pipeline
    • Ripretinib
    • Vimseltinib
    • DCC-3116
    • Preclinical Pipeline
    • Expanded Access
  • Our Medicine
    • QINLOCK® (ripretinib)
  • Who We Are
    • Management
  • Join Us
    • Open Positions

Main Utility

  • Patients & Caregivers
  • Healthcare Professionals
  • Clinical Trials
  • Presentation & Publications
  • Investors & News
twitter linkedin

Events and Presentations

Investor Relations
  • Overview
  • Press Releases
  • Events and Presentations
  • Historical Price Lookup
  • SEC Filings
  • Corporate Governance
    • Documents and Charters
    • Management
    • Board of Directors
  • Investor Resources
    • FAQs
    • Contact IR
    • Email Alerts

Presentations

Deciphera Pharmaceuticals Corporate Presentation – February 2024 4.9 MB
Deciphera Pharmaceuticals MOTION Top-Line Data and Third Quarter 2023 Conference Call Presentation 4.2 MB
Deciphera Pharmaceuticals AACR 2023 Investor Event Presentation 12.3 MB

Upcoming Events

More events are coming soon.

Past Events

More events are coming soon.
  • Print

    Print
  • RSS Feeds

    RSS Feeds
  • Email Alerts

    Email Alerts
  • Contact IR

    Contact IR

twitter linkedin
Contact us

Main navigation

  • Discovery Platform
  • Pipeline
    • Ripretinib
    • Vimseltinib
    • DCC-3116
    • Preclinical Pipeline
    • Expanded Access
  • Our Medicine
    • QINLOCK® (ripretinib)
  • Who We Are
    • Management
  • Join Us
    • Open Positions

Footer Utility

  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Web Accessibility Statement

© 2024 Deciphera Pharmaceuticals, Inc. QINLOCK and the QINLOCK logo are registered trademarks of Deciphera Pharmaceuticals, LLC. Deciphera and the Deciphera logo are trademarks of Deciphera Pharmaceuticals, LLC.